Mobile text-message support to help people stay on PrEP
Part of Immune system & allergy, Infections clinical trials.
This trial tests whether phone-based (iPhone/Android) text-message support can improve how consistently people use PrEP, an HIV prevention medicine. It may help you stay on track with refills and clinic visits, especially if you’re at higher risk of stopping PrEP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 15 years old
- Identify as a cisgender man, transgender man, or transgender woman
- In the past 12 months, have had sex with a cisgender man, a transgender woman, or someone assigned male at birth
- Have started PrEP within the past 6 months or be at higher risk of stopping (for example: missed clinic visits, under 30, Black or Latino, transgender identity, or using illicit substances)
- Have an iOS or Android phone with internet and be able to send/receive text messages; you can read/speak English or Spanish
- Not already be enrolled in another PrEP study and be able to participate for 12 months (and your situation must be safe for the study)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone-based program to help people who use drugs get more connected to HIV prevention services like PrEP. If you qualify, you'll use the app to get support and reminders, which may help reduce your risk of HIV.
This study looks at whether people already taking PrEP (a daily pill to prevent HIV) can share HIV self-test kits and PrEP information with friends or others in their social network. It may help you if you are on PrEP and want to help others learn about HIV prevention.
This study tests a '2-1-1' on-demand PrEP strategy for cisgender men who have sex with men. It aims to see if taking PrEP only around the time of sex is safe and effective. If you are interested in starting or currently taking PrEP this way, you may be eligible.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study tests a smartphone program to help HIV-negative men who have sex with men reduce meth use and improve PrEP adherence. It explores whether combining support for both behaviors is more effective than addressing them separately.
This study tests a text-message program to help people who use drugs learn about and start taking PrEP, a daily pill that prevents HIV. The program sends short messages on your phone to support you in staying HIV-free.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.